| Hashimoto K, Goromaru T |
Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-m... |
Neuropharmacology |
1990 |
| Hashimoto K, Goromaru T |
Reduction of [3H]6-nitroquipazine-labelled 5-hydroxytryptamine uptake ... |
Fundam Clin Pharmaco... |
1990 |
| Hashimoto K, Maeda H, Gor... |
Effects of benzylpiperazine derivatives on the neurotoxicity of 3,4-me... |
Brain Res |
1992 |
| Hashimoto K, Maeda H, Gor... |
Antagonism of 3,4-methylenedioxymethamphetamine-induced neurotoxicity ... |
Eur J Pharmacol |
1992 |
| Hashimoto K, Maeda H, Hir... |
Drug effects on distribution of [3H]3,4-methylenedioxymethamphetamine ... |
Eur J Pharmacol |
1993 |
| Shirayama Y, Hashimoto K,... |
3,4-Methylenedioxymethamphetamine (MDMA, ecstasy)-induced egr-1 mRNA i... |
Eur J Pharmacol |
2000 |
| Shimizu E, Watanabe H, Ko... |
Combined intoxication with methylone and 5-MeO-MIPT |
Prog Neuropsychophar... |
2007 |
| Zhang K, Hashimoto K |
Lack of Opioid System in the Antidepressant Actions of Ketamine |
Biol Psychiatry |
2019 |
